Quantinuum IPO terms target $12.7bn valuation

Quantinuum on Tuesday set terms for an initial public offering that could raise as much as $1.05 billion and value the Honeywell-backed quantum-computing company at up to $12.7 billion, putting a price on one of the year’s most closely watched frontier-technology flotations.

In its amended registration statement, Quantinuum said it plans to sell 21,052,632 shares at $45 to $50 each and list on Nasdaq. At the top of the range, gross proceeds would reach about $1.05 billion. The terms move the story from broad valuation talk to an actual price test for institutional buyers.

That range is below the $15 billion to $20 billion valuation chatter that circulated around the deal last week, a gap noted in CNBC analysis. The comedown does not necessarily signal weak demand. It suggests bankers are trying to leave less room for sticker shock in a market that has reopened for new issues, but not on the anything-goes terms of the 2021 cycle. Investors still need to be convinced that large technical ambitions can translate into repeatable commercial revenue.

Honeywell International Inc. is not using the IPO as a clean exit. Quantinuum said the proceeds will go to Quantinuum Holdings, while Honeywell-related entities are expected to retain 49.1 per cent of the voting power after the listing, according to the SEC filing. That leaves Honeywell in effective control after the float and makes the transaction look as much like a financing round and partial monetisation as a handoff to a fully independent shareholder base.

Hazra’s message in the filing was about timeline and technical credibility, not valuation bragging.

“We believe that we are executing a roadmap to the first commercial-scale, fully fault-tolerant quantum computer before the end of this decade, the Apollo system.”

— Rajeeb Hazra, chief executive officer, in Quantinuum’s S-1/A filing

How investors will read the terms

The sector backdrop has improved since last week, when CNBC reported that the US government planned $2 billion in grants and minority equity stakes for a group of quantum companies. That report lifted listed quantum names and gave private companies a friendlier mood for fundraising. Even so, Quantinuum is still coming to market through a conventional stock sale, asking new shareholders to fund expensive hardware, research and scale-up with no shortcut around the usual IPO scrutiny.

Bloomberg reported that a $12.7 billion valuation would still put Quantinuum above some listed quantum peers. That is the balance investors have to weigh. Scarcity helps: there are few pure-play quantum names of scale, and Honeywell gives the deal a blue-chip sponsor. Execution risk remains high because the sector is still early in converting scientific progress into durable revenue.

That mix points to selective demand rather than a blank cheque. Fund managers can buy into the national-policy tailwind and the long-term promise of quantum computing while still demanding valuation discipline up front. In practice, the order book will show whether buyers are willing to pay software-style prices for a company that still has years of heavy investment ahead.

Strong demand near the top of the range would suggest public investors are prepared to underwrite a long-duration quantum bet, not only the faster-revenue AI application names that have absorbed much of this year’s enthusiasm. A lower price or a smaller deal would send a narrower message: the IPO window is open for ambitious technology stories, but only on terms that leave more upside for new shareholders once trading starts.